WASHINGTON (AP) — Deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal and therefore can be challenged in court, the Supreme Court said Monday.
The justices voted 5-3 to allow the government to inspect and challenge what it calls “pay-for-delay” deals or “reverse payment settlements.”
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.